Skip to main content

Closed

TPST: Tempest Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-499.8%

Financially safe

Stretched

Debt / equity9.55×

Interest coverage-628.4×

Current ratio0.74×

Tempest Therapeutics, Inc.

TPSTNASDAQ Capital Market·USD·Closed

Tempest Therapeutics, Inc.

TPSTNASDAQ·USD·Closed

$0.89

+1.38%

$0.89

+$0.01 (1.38%)

52W Range

0thpctl

Volume

0.37×avg

Mkt Cap

3.94MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.37×avg

Market Cap

3.94MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings